Industry Insights
The global amniocentesis needle market size will grow by USD 31.6 million during 2019-2023. The market’s growth momentum is expected to accelerate throughout the forecast period because of the steady increase in the year-over-year growth.
The market report provides a detailed analysis of the market by application (amniocentesis, fetal blood transfusion, amnioreduction, and others), end-users (hospitals, diagnostic laboratories, and others), and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including BD, Cardinal Health, Integra LifeSciences, Medline Industries, Inc., Smiths Group plc, and The Cooper Companies, Inc.
An amniocentesis needle is designed to pass through the abdominal aperture of the uterus for the aspiration of small quantitative amniotic fluid through obstetric and gynecological processes.
Key Insights from Amniocentesis Needle Market – Global Forecast 2019-2023
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the market report
The growing preference for non-invasive and minimally invasive diagnostic procedures is one of the critical reasons that will drive market growth. Advances in the medical field and the emergence of preventive medicines encourage women to prefer non-invasive and minimally-invasive diagnostic procedures. Non-invasive prenatal test (NIPT) is the most effective method of screening for common autosomal aneuploidies and helps in determining the risks of having a fetus with the abnormal number of chromosomes. With women focusing on preparing for the birth of the baby with Down syndrome, the preference for NIPT is high. This will subsequently drive the demand for these needles which will lead to the growth of the amniocentesis needle market size.
Innovations and developments in technology have further resulted in the evolution of minimally and non-invasive techniques and equipment. Technological advancements enable physicians to diagnose genetic conditions such as single-gene and aneuploidy disorders based on samples obtained through amniocentesis or CVS. These conditions cannot be non-invasively screened. Similarly, advancements such as the development of prenatal ultrasound are used for a better understanding of fetal pathophysiology. This technique will fuel advances in prenatal diagnostics such as amniocentesis using these needles. Such technological advancements coupled with the preference for minimally invasive diagnostic procedures will drive amniocentesis needle market growth at a CAGR of almost 4% during the forecast period.
Industry Analysis
Quantitative Data
|
Qualitative Data
|
Application Insights
The application segment has been segregated into amniocentesis, fetal blood transfusion, amnioreduction, and others. The amniocentesis segment accounted for the highest amniocentesis needle market share in 2018. During the forecast period, the segment will grow at a faster pace than the overall market. The fetal blood transfusion and amnioreduction segments will grow at a slower pace than the overall market.
The amniocentesis segment will account for the highest market share because of the growing demand for amniocentesis needles. This is mainly because of factors such as the increasing incidence of conditions such as Down Syndrome, the need for prenatal diagnosis, and the high adoption of amniocentesis procedure.
Regional Insights
North America accounted for the highest market share in 2018. Though the market’s growth in the region will be slower than the growth of the market in Asia, the region will account for the largest amniocentesis needle market share throughout the forecast period.
The prevalence of a high number of congenital disabilities and genetic disorders in infants is one of the significant factors for the high growth of the amniocentesis needle market size in the region.
Top Amniocentesis Needle Companies
The market is moderately fragmented. To help clients improve their position, the amniocentesis needle market analysis report provides information on the competitive landscape and the products offered by various companies. Moreover, the market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
The report offers a detailed analysis of several leading amniocentesis needle manufacturers, including:
- BD
- Cardinal Health
- Integra LifeSciences
- Medline Industries, Inc.
- Smiths Group plc
- The Cooper Companies, Inc.
Segments Covered in the Report
Amniocentesis needle market by application
- Amniocentesis
- Fetal blood transfusion
- Amnioreduction
- Others
Amniocentesis needle market by end-users
- Hospitals
- Diagnostic laboratories
- Others
Amniocentesis needle market by region
- Asia
- Europe
- North America
- ROW
Key Highlights of the Amniocentesis Needle Market Forecast Report for the Period 2019-2023
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the amniocentesis needle market size during the next five years
- Precise estimation of the global amniocentesis needle market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of companies
We can help! Our analysts can customize the market research report to meet your requirements. Get in touch